Dynamics in Post-pandemic Global Parkinson's Disease Industry: Supply and Demand, Markets and Prices 2021-2027
Table of Contents
1 Product Introduction and Overview
- 1.1 Product Definition
- 1.2 Product Specification
- 1.3 Global Market Overview
- 1.3.1 Global Parkinson's Disease Market Status and Forecast (2016-2027)
- 1.3.2 Global Parkinson's Disease Sales Value CAGR by Region
- 1.4 Market Drivers, Inhibitors
- 1.4.1 Market Drivers
- 1.4.2 Market Inhibitors
- 1.4.3 COVID-19 Impact Analysis
2 Global Parkinson's Disease Supply by Company
- 2.1 Global Parkinson's Disease Sales Value by Company
- 2.2 Parkinson's Disease Sales Area of Main Manufacturers
- 2.3 Trend of Concentration Rate
3 Global and Regional Parkinson's Disease Market Status by Category
- 3.1 Parkinson's Disease Category Introduction
- 3.1.1 Carbidopa/Levodopa
- 3.1.2 Dopamine Receptor Agonists
- 3.1.3 MAO-Inhibitors
- 3.2 Global Parkinson's Disease Market by Category
- 3.3 North America: by Category
- 3.4 Europe: by Category
- 3.5 Asia Pacific: by Category
- 3.6 Central & South America: by Category
- 3.7 Middle East & Africa: by Category
4 Global and Regional Parkinson's Disease Market Status by End User/Segment
- 4.1 Parkinson's Disease Segment by End User/Segment
- 4.1.1 Hospitals
- 4.1.2 Clinics
- 4.2 Global Parkinson's Disease Market by End User/Segment
- 4.3 North America: by End User/Segment
- 4.4 Europe: by End User/Segment
- 4.5 Asia Pacific: by End User/Segment
- 4.6 Central & South America: by End User/Segment
- 4.7 Middle East & Africa: by End User/Segment
5 Global Parkinson's Disease Market Status by Region
- 5.1 Global Parkinson's Disease Market by Region
- 5.2 North America Parkinson's Disease Market Status
- 5.3 Europe Parkinson's Disease Market Status
- 5.4 Asia Pacific Parkinson's Disease Market Status
- 5.5 Central & South America Parkinson's Disease Market Status
- 5.6 Middle East & Africa Parkinson's Disease Market Status
6 North America Parkinson's Disease Market Status
- 6.1 North America Parkinson's Disease Market by Country
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
7 Europe Parkinson's Disease Market Status
- 7.1 Europe Parkinson's Disease Market by Country
- 7.2 Germany
- 7.3 France
- 7.4 UK
- 7.5 Italy
- 7.6 Russia
- 7.7 Spain
8 Asia Pacific Parkinson's Disease Market Status
- 8.1 Asia Pacific Parkinson's Disease Market by Country
- 8.2 China
- 8.3 Japan
- 8.4 Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australasia
9 Central & South America Parkinson's Disease Market Status
- 9.1 Central & South America Parkinson's Disease Market by Country
- 9.2 Brazil
- 9.3 Argentina
- 9.4 Colombia
10 Middle East & Africa Parkinson's Disease Market Status
- 10.1 Middle East & Africa Parkinson's Disease Market by Country
- 10.2 Iran
- 10.3 Israel
- 10.4 Turkey
- 10.5 South Africa
- 10.8 Saudi Arabia
11 Major Downstream Customers Analysis
- 11.1 Customer One Analysis
- 11.2 Customer Two Analysis
- 11.3 Customer Three Analysis
- 11.4 Customer Four Analysis
12 Global Parkinson's Disease Market Forecast by Category and by End User/Segment
- 12.1 Global Parkinson's Disease Sales Value Forecast (2022-2027)
- 12.2 Global Parkinson's Disease Forecast by Category
- 12.3 Global Parkinson's Disease Forecast by End User/Segment
13 Global Parkinson's Disease Market Forecast by Region/Country
- 13.1 Global Parkinson's Disease Market Forecast by Region (2022-2027)
- 13.2 North America Market Forecast
- 13.3 Europe Market Forecast
- 13.4 Asia Pacific Market Forecast
- 13.5 Central & South America Market Forecast
- 13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
- 14.1 Wockhardt
- 14.1.1 Company Information
- 14.1.2 Parkinson's Disease Product Introduction
- 14.1.3 Wockhardt Parkinson's Disease Sales Value, Gross Margin and Global Share (2019-2021)
- 14.1.4 SWOT Analysis
- 14.2 UCB
- 14.2.1 Company Information
- 14.2.2 Parkinson's Disease Product Introduction
- 14.2.3 UCB Parkinson's Disease Sales Value, Gross Margin and Global Share (2019-2021)
- 14.2.4 SWOT Analysis
- 14.3 Teva
- 14.3.1 Company Information
- 14.3.2 Parkinson's Disease Product Introduction
- 14.3.3 Teva Parkinson's Disease Sales Value, Gross Margin and Global Share (2019-2021)
- 14.3.4 SWOT Analysis
- 14.4 Sun Pharma
- 14.4.1 Company Information
- 14.4.2 Parkinson's Disease Product Introduction
- 14.4.3 Sun Pharma Parkinson's Disease Sales Value, Gross Margin and Global Share (2019-2021)
- 14.4.4 SWOT Analysis
- 14.5 Novartis
- 14.5.1 Company Information
- 14.5.2 Parkinson's Disease Product Introduction
- 14.5.3 Novartis Parkinson's Disease Sales Value, Gross Margin and Global Share (2019-2021)
- 14.5.4 SWOT Analysis
- 14.6 Merck
- 14.6.1 Company Information
- 14.6.2 Parkinson's Disease Product Introduction
- 14.6.3 Merck Parkinson's Disease Sales Value, Gross Margin and Global Share (2019-2021)
- 14.6.4 SWOT Analysis
- 14.7 Lundbeck
- 14.7.1 Company Information
- 14.7.2 Parkinson's Disease Product Introduction
- 14.7.3 Lundbeck Parkinson's Disease Sales Value, Gross Margin and Global Share (2019-2021)
- 14.7.4 SWOT Analysis
- 14.8 GSK
- 14.8.1 Company Information
- 14.8.2 Parkinson's Disease Product Introduction
- 14.8.3 GSK Parkinson's Disease Sales Value, Gross Margin and Global Share (2019-2021)
- 14.8.4 SWOT Analysis
- 14.9 Boehringer Ingelheim
- 14.9.1 Company Information
- 14.9.2 Parkinson's Disease Product Introduction
- 14.9.3 Boehringer Ingelheim Parkinson's Disease Sales Value, Gross Margin and Global Share (2019-2021)
- 14.9.4 SWOT Analysis
- 14.10 Bausch Health
- 14.10.1 Company Information
- 14.10.2 Parkinson's Disease Product Introduction
- 14.10.3 Bausch Health Parkinson's Disease Sales Value, Gross Margin and Global Share (2019-2021)
- 14.10.4 SWOT Analysis
- 14.11 Amneal + Impax
- 14.12 Acadia
- 14.13 AbbVie
15 Conclusion
16 Methodology
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Parkinson's Disease market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Parkinson's Disease market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Segmented by End User/Segment
Hospitals
Clinics
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Wockhardt
UCB
Teva
Sun Pharma
Novartis
Merck
Lundbeck
GSK
Boehringer Ingelheim
Bausch Health
Amneal + Impax
Acadia
AbbVie